Novo Nordisk A/S (NYSE:NVO) Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 Novo Nordisk Earnings Conference Call. [Operator ...

It's been a rocky few months for Novo Nordisk. Prescription data from IQVIA suggests Novo's obesity drug Wegovy is losing ground to rival Zepbound from Eli Lilly. Wegovy's potential successor, ...

Novo Nordisk NVO recently underwent a major leadership transition, as Lars Fruergaard Jørgensen stepped down as CEO on Aug. 7, 2025, after leading the company since 2017. His tenure saw remarkable ...

Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds ...

“All we are saying, Mr. Jorgensen, is treat the American people the same way that you treat people all over the world,” Sanders said to the Novo Nordisk CEO. “Stop ripping us off.” Sanders compared ...

Novo Nordisk shareholders approved the appointment of Lars Rebien Sorensen as new chair as part of a broader move to shake up the company's board of directors at a special meeting on Friday. The ...